Robert Lippe
Chief Operating Officer bei Liquidia Technologies, Inc.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Robert A.
Lippe currently works at Liquidia Technologies, Inc., as Chief Operations Officer from 2015.
Mr. Lippe also formerly worked at Genentech, Inc., as Head-Manufacturing from 2002 to 2011, Ironwood Pharmaceuticals, Inc., as Head-Global Operations & & Operational Excellence from 2011 to 2014, Alexza Pharmaceuticals, Inc., as Chief Operations Officer & Executive VP-Operations from 2014 to 2015, Lawrence Livermore National Laboratory, as Manager-Assurance & Facility from 1992 to 2002, and Liquidia Corp., as Chief Operating Officer from 2020 to 2024.
Mr. Lippe received his undergraduate degree from US Coast Guard Academy and graduate degree and Masters Business Admin degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION
0,25% | 30.11.2023 | 193 788 ( 0,25% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Robert Lippe
| Unternehmen | Position | Beginn |
|---|---|---|
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Chief Operating Officer | 01.06.2015 |
Ehemalige bekannte Positionen von Robert Lippe
| Unternehmen | Position | Ende |
|---|---|---|
| LIQUIDIA CORPORATION | Chief Operating Officer | 15.01.2024 |
| ALEXZA PHARMACEUTICALS, INC. | Chief Operating Officer | 12.06.2015 |
| IRONWOOD PHARMACEUTICALS, INC. | Chief Operating Officer | 01.02.2014 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2011 |
Lawrence Livermore National Laboratory
 Lawrence Livermore National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Livermore National Laboratory provides nuclear testing services. The Laboratory's security needs include countering the proliferation of weapons of mass destruction and strengthening homeland security against the terrorist use of such weapons. The company was founded in 1952 and is headquartered in Livermore, CA. | Corporate Officer/Principal | 01.05.2002 |
Ausbildung von Robert Lippe
| US Coast Guard Academy | Undergraduate Degree |
| University of California, Berkeley | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Lawrence Livermore National Laboratory
Lawrence Livermore National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Livermore National Laboratory provides nuclear testing services. The Laboratory's security needs include countering the proliferation of weapons of mass destruction and strengthening homeland security against the terrorist use of such weapons. The company was founded in 1952 and is headquartered in Livermore, CA. | Commercial Services |
| Liquidia Corp. |
